Development of Betulin-Loaded Nanostructured Lipid Carriers for the Management of Imiquimod-Induced Psoriasis

A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis

Gerald G. Krueger, Richard G. Langley, Craig L. Leonardi et al. · New England Journal of Medicine · 2007 · 785 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)

Jia-You Fang, Chia-Lang Fang, Chi-Hsien Liu et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2008 · 510 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Nanoparticles and their interactions with the dermal barrier

Marc Schneider, Frank Stracke, Steffi Hansen et al. · Dermato-Endocrinology · 2009 · 466 citations · Full text

Pharmacy, Dermatology, Pharmaceutics +17

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis

Christopher S. Carlin, Steven R. Feldman, James G. Krueger et al. · Journal of the American Academy of Dermatology · 2004 · 284 citations

Medicine, Dermatology, Dermatopathology +10

Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice

Jun Sun, Yi Zhao, HU Jin-hong · PLoS ONE · 2013 · 233 citations · Full text

Medicine, Dermatology, Pharmacology +17